Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: juneau_boy who wrote (435)	5/2/2000 10:56:00 PM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 3559

<<And another.....what is the timeline and potential of BDNF?>> Results from ongoing trials should start coming by year end. Regards the potential, your guess is as good as my. I do believe that BDNF utility will be more than simple ALS population, the some opinion have Sumitomo. However, based on increased short position for last month, some investors do not think some. This may be part of the price stabilization (read deflation, by certain underwriters) before secondary. Soon or later they will cover their positions. Miljenko